Delivery Order SPE2DR25D2006-SPE2DR26F57PN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,204.86 to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency has awarded a delivery order valued at $1,668.62 to AmerisourceBergen Drug Corp for the supply of Dorzolamide-Timolol eye drops in 10-milliliter quantities. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of January 23, 2026. The contract was executed on January 22, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this...
- The Defense Logistics Agency (DLA) awarded a $1,103.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml), with an ultimate completion date of November 19, 2025. This delivery order, issued on November 18, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $1,364.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dorzolamide-Timolol eye drops in 10ml quantities. The contract, with an ultimate completion date of December 22, 2025, represents a non-set-aside award made on December 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,453.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dorzolamide-Timolol eye drops in 10 milliliter quantities. This non-set-aside competitive award was issued on January 16, 2026, with an ultimate completion date of January 20, 2026. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Dorzolamide-Timolol eye drops in 10ml quantities under a firm fixed-price contract valued at $4,762.14. This delivery order, which carries a completion date of November 21, 2025, represents a non-set-aside competitive award and serves as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $4,258.38 to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,813.11 to AmerisourceBergen Drug Corp for the supply of Dorzolamide-Timolol Eye Drops (10ml) on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Dorzolamide-Timolol Eye Drops (10ml) on January 5, 2026, with a ceiling value of $1,058.54 and an ultimate completion date of January 6, 2026. This competitively awarded, non-set-aside delivery order employs firm fixed price pricing and represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. The place of performance is AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dorzolamide-Timolol eye drops (10ml) with a contract ceiling value of $1,318.75. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F57PNDelivery Order
The Defense Logistics Agency awarded a $2,359.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dorzolamide-Timolol eye drops in 10-milliliter quantities. This delivery order, issued on January 23, 2026, with an ultimate completion date of January 26, 2026, represents a child contract under a larger indefinite delivery vehicle. The award was made on a full and open competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent organization being Cencora, Inc., a major pharmaceutical distribution and healthcare solutions provider. This delivery order falls under AmerisourceBergen Drug Corp's primary indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Dorzolamide-Timolol eye drops are part of the extensive pharmaceutical commodities portfolio available under this IDC, which serves military treatment facilities, the Defense Health Agency, the U.S. Coast Guard, and other federal government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/22/26 |